New study checks if emicizumab helps Kids' joints and movement
NCT ID NCT07190118
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 27 times
Summary
This study will follow 20 children with hemophilia A to see how the drug emicizumab affects their muscles and joints. Researchers will measure pain, balance, and how well kids can move and do daily activities. The goal is to understand if this treatment helps keep their bodies healthy and active.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hasan Kalyoncu University
Gaziantep, Gaziantep, (505) 090-5846, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.